Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$8.06 +0.14 (+1.70%)
As of 03:59 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Key Stats

Today's Range
$7.97
$8.08
50-Day Range
$6.24
$8.12
52-Week Range
$4.79
$8.58
Volume
208,566 shs
Average Volume
375,276 shs
Market Capitalization
$31.65 billion
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

Bayer extends contract of CEO until March 2029
Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
Bayer: Upside Compelling - Buy
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $4.88 on January 1st, 2025. Since then, BAYRY stock has increased by 65.1% and is now trading at $8.0550.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its quarterly earnings results on Tuesday, May, 13th. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.02. The business earned $15.27 billion during the quarter, compared to the consensus estimate of $13.39 billion. Bayer Aktiengesellschaft had a negative net margin of 7.26% and a positive trailing twelve-month return on equity of 13.94%.

Bayer Aktiengesellschaft subsidiaries include Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and others.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 5/12 Dividend
4/29/2025
Record date for 5/12 Dividend
4/30/2025
Dividend Payable
5/12/2025
Last Earnings
5/13/2025
Today
7/16/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
CIK
1144145
Employees
92,815
Year Founded
1863

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.15
P/E Growth
N/A
Net Income
-$2.76 billion
Net Margins
-7.26%
Pretax Margin
-6.83%
Return on Equity
13.94%
Return on Assets
4.09%

Debt

Debt-to-Equity Ratio
1.07
Current Ratio
1.25
Quick Ratio
0.79

Sales & Book Value

Annual Sales
$50.44 billion
Price / Sales
0.63
Cash Flow
$3.85 per share
Price / Cash Flow
2.09
Book Value
$8.82 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
3,929,700,000
Free Float
N/A
Market Cap
$31.65 billion
Optionable
Not Optionable
Beta
0.86

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners